BETAPACE Side Effects

6988423-8 | Dyspnoea
on Aug 16, 2010 Male patient from UNITED STATES , 65 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Betapace (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea. Betapace dosage: .

6942537-7 | Atrial Fibrillation
Patient was taking Betapace (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?) on Jul 26, 2010 from UNITED STATES Additional patient health information: Female patient , 72 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and. Betapace dosage: . During the same period patient was treated with PRAVACHOL (View Pravachol Review and Pravachol Label ), AVAPRO (View Avapro Review and Avapro Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), HYDRALAZINE (View Hydralazine Review and Hydralazine Label ), CARDURA (View Cardura Review and Cardura Label ).

6862614-9 | Arrhythmia
Adverse event was reported on Jun 17, 2010 by a Female patient taking Betapace (View Usage) (Dosage: ) was diagnosed with arrhythmia (What is arrhythmia?) and. Location: UNITED STATES , 83 years of age, After Betapace was administered, patient had the following side effects: arrhythmia (What is arrhythmia?).

6857334-0 | Atrial Fibrillation
on Jun 16, 2010 Female patient from UNITED STATES , 72 years of age, was treated with Betapace (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?). Betapace dosage: .


6856733-0 | Vision Blurred
on Jun 29, 2010 Female patient from UNITED STATES , 13 years of age, was diagnosed with syncope and was treated with Betapace (View Usage). Patient had the following side effects: vision blurred. Betapace dosage: Total Daily Dose: 80 Mg Unit Dose: 40 Mg. Patient was hospitalized.

6831827-4 | Vision Blurred
Patient was taking Betapace (View Usage). After Betapace was administered, patient had the following side effects: vision blurred on Jun 29, 2010 from UNITED STATES Additional patient health information: Female patient , 13 years of age, was diagnosed with syncope and. Betapace dosage: Total Daily Dose: 80 Mg Unit Dose: 40 Mg. Patient was hospitalized.

6800978-2 | Arrhythmia
Adverse event was reported on Jun 17, 2010 by a Female patient taking Betapace (View Usage) (Dosage: ) was diagnosed with arrhythmia (What is arrhythmia?) and. Location: UNITED STATES , 83 years of age, Patient experienced the following unwanted or unexpected effects: arrhythmia (What is arrhythmia?).

6766488-6 | Arrhythmia, Cardiac Ablation
on Apr 30, 2010 Male patient from UNITED STATES , 61 years of age, was diagnosed with ventricular arrhythmia and was treated with Betapace (View Usage). Patient had the following side effects: arrhythmia (What is arrhythmia?), cardiac ablation. Betapace dosage: . During the same period patient was treated with BETAPACE AF (View Betapace Af Review and Betapace Af Label ). Patient was hospitalized.

6722431-7 | Arrhythmia, Cardiac Ablation
on Apr 30, 2010 Male patient from UNITED STATES , 61 years of age, was diagnosed with ventricular arrhythmia and was treated with Betapace (View Usage). After Betapace was administered, patient had the following side effects: arrhythmia (What is arrhythmia?), cardiac ablation. Betapace dosage: . During the same period patient was treated with BETAPACE AF (View Betapace Af Review and Betapace Af Label ). Patient was hospitalized.

6710518-4 | Cardiac Arrest, Multi-organ Failure, Peripheral Ischaemia, Retroperitoneal Haemorrhage
Patient was taking Betapace (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), multi-organ failure, peripheral ischaemia, retroperitoneal haemorrhage on Mar 10, 2010 from FRANCE Additional patient health information: Female patient , 40 years of age, . Betapace dosage: 4.8 Grams. During the same period patient was treated with ISOPTIN (7.2 Grams) (View Isoptin Review and Isoptin Label ). Patient was hospitalized.

6707547-3 | Arrhythmia
Adverse event was reported on Dec 04, 2009 by a Male patient taking Betapace (View Usage) (Dosage: ) . Location: UNITED STATES , 54 years of age, Patient had the following side effects: arrhythmia (What is arrhythmia?).

6648477-5 | Cardiac Arrest, Multi-organ Failure, Peripheral Ischaemia, Retroperitoneal Haemorrhage
on Mar 10, 2010 Female patient from FRANCE , 40 years of age, was treated with Betapace (View Usage). After Betapace was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), multi-organ failure, peripheral ischaemia, retroperitoneal haemorrhage. Betapace dosage: 4.8 Grams. During the same period patient was treated with ISOPTIN (7.2 Grams) (View Isoptin Review and Isoptin Label ). Patient was hospitalized.

6621107-4 | Atrial Fibrillation
on Feb 09, 2010 Female patient from UNITED STATES , 78 years of age, weighting 216.1 lb, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Betapace (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?). Betapace dosage: . Patient was hospitalized.

6594488-8 | Atrial Fibrillation
Patient was taking Betapace (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?) on Feb 09, 2010 from UNITED STATES Additional patient health information: Female patient , 78 years of age, weighting 216.1 lb, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and. Betapace dosage: . Patient was hospitalized.

6568927-2 | Communication Disorder, Confusional State, Dizziness, Dysstasia, Fatigue, Hemiparesis, Hyperhidrosis, Incoherent, Malaise
Adverse event was reported on Feb 01, 2010 by a Male patient taking Betapace (View Usage) (Dosage: 80 Mg 2x Day; Gave 120 Mg On 7/14/09 At 0937) . Location: UNITED STATES , 73 years of age, weighting 164.0 lb, After Betapace was administered, patient had the following side effects: communication disorder, confusional state, dizziness (What is dizziness?), dysstasia, fatigue, hemiparesis, hyperhidrosis, incoherent, malaise. Patient was hospitalized.

6567281-X | Heart Rate Decreased
on Jan 06, 2010 Female patient from UNITED STATES , 74 years of age, was treated with Betapace (View Usage). Patient experienced the following unwanted or unexpected effects: heart rate decreased. Betapace dosage: .

6567257-2 | Bradycardia
on Jan 27, 2010 Male patient from UNITED STATES , 63 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Betapace (View Usage). Patient had the following side effects: bradycardia. Betapace dosage: . During the same period patient was treated with BIOSEDRA (View Biosedra Review and Biosedra Label ).

6555462-0 | Bradycardia
Patient was taking Betapace (View Usage). After Betapace was administered, patient had the following side effects: bradycardia on Jan 27, 2010 from UNITED STATES Additional patient health information: Male patient , 63 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and. Betapace dosage: . During the same period patient was treated with BIOSEDRA (View Biosedra Review and Biosedra Label ).

6529281-5 | Vision Blurred
Adverse event was reported on Dec 07, 2009 by a Male patient taking Betapace (View Usage) (Dosage: Total Daily Dose: 160 Mg) . Location: UNITED STATES , 56 years of age, Patient experienced the following unwanted or unexpected effects: vision blurred.

6529280-3 | Alopecia, Hearing Impaired, Hypersensitivity, Pruritus, Visual Impairment
on Dec 07, 2009 Female patient from UNITED STATES , 84 years of age, weighting 147.7 lb, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Betapace (View Usage). Patient had the following side effects: alopecia, hearing impaired, hypersensitivity, pruritus, visual impairment. Betapace dosage: Unit Dose: 40 Mg. During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ), PEPCID (View Pepcid Review and Pepcid Label ), POTASSIUM (View Potassium Review and Potassium Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), DIOVAN (View Diovan Review and Diovan Label ), GARAPENTINO (View Garapentino Review and Garapentino Label ).

6529276-1 | Adverse Event
on Dec 07, 2009 Female patient from GERMANY , 79 years of age, was treated with Betapace (View Usage). After Betapace was administered, patient had the following side effects: adverse event. Betapace dosage: .

6529274-8 | Atrial Fibrillation
Patient was taking Betapace (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?) on Dec 07, 2009 from GERMANY Additional patient health information: Female patient , 72 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and. Betapace dosage: . During the same period patient was treated with RYTHMOL (View Rythmol Review and Rythmol Label ).

6529269-4 | Heart Rate Irregular
Adverse event was reported on Dec 07, 2009 by a Female patient taking Betapace (View Usage) (Dosage: Total Daily Dose: 160 Mg Unit Dose: 80 Mg) was diagnosed with atrial fibrillation (What is atrial fibrillation?), hypertension and. Location: UNITED STATES , 69 years of age, weighting 125.7 lb, Patient had the following side effects: heart rate irregular. During the same period patient was treated with TENORMIN (View Tenormin Review and Tenormin Label ), COUMADIN (View Coumadin Review and Coumadin Label ).

6529268-2 | Pain
on Dec 07, 2009 Male patient from UNITED STATES , 66 years of age, weighting 172.0 lb, was diagnosed with high density lipoprotein increased and was treated with Betapace (View Usage). After Betapace was administered, patient had the following side effects: pain (What is pain?). Betapace dosage: . During the same period patient was treated with NIASPAN (Total Daily Dose: 500 Mg Unit Dose: 500 Mg) (View Niaspan Review and Niaspan Label ), CRESTOR (View Crestor Review and Crestor Label ), PLAVIX (Total Daily Dose: 75 Mg Unit Dose: 75 Mg) (View Plavix Review and Plavix Label ), ATENOLOL (Total Daily Dose: 25 Mg Unit Dose: 25 Mg) (View Atenolol Review and Atenolol Label ), ACETYLSALICYLIC ACID (Total Daily Dose: 81 Mg Unit Dose: 81 Mg) (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ).

6524863-9 | Arrhythmia
on Dec 04, 2009 Male patient from UNITED STATES , 54 years of age, was treated with Betapace (View Usage). Patient experienced the following unwanted or unexpected effects: arrhythmia (What is arrhythmia?). Betapace dosage: .

6524831-7 | No Adverse Event
Patient was taking Betapace (View Usage). Patient had the following side effects: no adverse event on Dec 04, 2009 from UNITED STATES Additional patient health information: Male patient , 60 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and. Betapace dosage: Total Daily Dose: 240 Mg Unit Dose: 120 Mg.

6524126-1 | Asthenia, Blood Glucose Increased, Decreased Appetite, Fatigue, Muscle Spasms, Urine Flow Decreased
Adverse event was reported on Dec 30, 2009 by a Male patient taking Betapace (View Usage) (Dosage: 80 Mg Twice Daily Mouth) was diagnosed with atrial fibrillation (What is atrial fibrillation?) and. Location: UNITED STATES , 73 years of age, weighting 200.0 lb, After Betapace was administered, patient had the following side effects: asthenia, blood glucose increased, decreased appetite, fatigue, muscle spasms, urine flow decreased.

6505009-X | Atrial Fibrillation, Bronchospasm, Dyspnoea
on Dec 07, 2009 Female patient from ICELAND , 73 years of age, weighting 125.7 lb, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Betapace (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), bronchospasm, dyspnoea. Betapace dosage: Total Daily Dose: 240 Mg Unit Dose: 120 Mg. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CARTIA XT (View Cartia Xt Review and Cartia Xt Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), LYRICA (View Lyrica Review and Lyrica Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), ZYDONE (View Zydone Review and Zydone Label ). Patient was hospitalized.

6450098-4 | Atrial Fibrillation
on Oct 26, 2009 Female patient from GERMANY , 72 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Betapace (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?). Betapace dosage: . During the same period patient was treated with RYTHMOL (View Rythmol Review and Rythmol Label ).

6448581-0 | Adverse Event
Patient was taking Betapace (View Usage). After Betapace was administered, patient had the following side effects: adverse event on Oct 21, 2009 from GERMANY Additional patient health information: Female patient , 79 years of age, . Betapace dosage: .

6437813-0 | Vision Blurred
Adverse event was reported on Oct 12, 2009 by a Male patient taking Betapace (View Usage) (Dosage: Total Daily Dose: 160 Mg) . Location: UNITED STATES , 56 years of age, Patient experienced the following unwanted or unexpected effects: vision blurred.

6401064-6 | Atrial Fibrillation
on Sep 22, 2009 Female patient from GERMANY , 72 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Betapace (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?). Betapace dosage: . During the same period patient was treated with RYTHMOL (View Rythmol Review and Rythmol Label ).

6378967-4 | No Adverse Event
on Sep 04, 2009 Female patient from UNITED STATES , 79 years of age, was treated with Betapace (View Usage). After Betapace was administered, patient had the following side effects: no adverse event. Betapace dosage: .

6342998-0 | Atrial Fibrillation
Patient was taking Betapace (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?) on Aug 07, 2009 from GERMANY Additional patient health information: Male patient , 70 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and. Betapace dosage: .

6334690-3 | Vision Blurred
Adverse event was reported on Jul 30, 2009 by a Male patient taking Betapace (View Usage) (Dosage: Total Daily Dose: 160 Mg) . Location: UNITED STATES , 56 years of age, Patient had the following side effects: vision blurred.

6311480-9 | Pain
on Jul 17, 2009 Male patient from UNITED STATES , 66 years of age, weighting 172.0 lb, was diagnosed with high density lipoprotein increased and was treated with Betapace (View Usage). After Betapace was administered, patient had the following side effects: pain (What is pain?). Betapace dosage: . During the same period patient was treated with NIASPAN (Total Daily Dose: 500 Mg Unit Dose: 500 Mg) (View Niaspan Review and Niaspan Label ), CRESTOR (View Crestor Review and Crestor Label ), PLAVIX (Total Daily Dose: 75 Mg Unit Dose: 75 Mg) (View Plavix Review and Plavix Label ), ATENOLOL (Total Daily Dose: 25 Mg Unit Dose: 25 Mg) (View Atenolol Review and Atenolol Label ), ASPIRIN (Total Daily Dose: 81 Mg Unit Dose: 81 Mg) (View Aspirin Review and Aspirin Label ).

6267075-9 | Atrial Fibrillation
on Jun 10, 2009 Male patient from GERMANY , 70 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Betapace (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?). Betapace dosage: .

6184072-2 | Vision Blurred
Patient was taking Betapace (View Usage). Patient had the following side effects: vision blurred on May 01, 2009 from UNITED STATES Additional patient health information: Male patient , 69 years of age, weighting 174.2 lb, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and. Betapace dosage: As Used: 80 Mg. During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ).

6158462-8 | Vision Blurred
Adverse event was reported on Apr 10, 2009 by a Male patient taking Betapace (View Usage) (Dosage: As Used: 80 Mg) was diagnosed with atrial fibrillation (What is atrial fibrillation?) and. Location: UNITED STATES , 69 years of age, weighting 174.2 lb, After Betapace was administered, patient had the following side effects: vision blurred. During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ).

5954289-8 | No Adverse Event
on Oct 17, 2008 Male patient from UNITED STATES , 60 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Betapace (View Usage). Patient experienced the following unwanted or unexpected effects: no adverse event. Betapace dosage: Total Daily Dose: 240 Mg Unit Dose: 120 Mg.

5950151-5 | Dyspnoea, Heart Rate Decreased
on Apr 01, 2008 Female patient from UNITED STATES , 79 years of age, was diagnosed with unevaluable event and was treated with Betapace (View Usage). Patient had the following side effects: dyspnoea, heart rate decreased. Betapace dosage: Unit Dose: 120 Mg.

5950147-3 | Fatigue, Muscle Spasms, Thyroid Function Test Abnormal
Patient was taking Betapace (View Usage). After Betapace was administered, patient had the following side effects: fatigue, muscle spasms, thyroid function test abnormal on Jun 18, 2008 from UNITED STATES Additional patient health information: Female patient , 73 years of age, weighting 185.2 lb, was diagnosed with ventricular fibrillation and. Betapace dosage: Unit Dose: 40 Mg. During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), BAYER ASA (View Bayer Asa Review and Bayer Asa Label ), LASIX (View Lasix Review and Lasix Label ), ZOCOR (View Zocor Review and Zocor Label ).

5950141-2 | Heart Rate Irregular
Adverse event was reported on Jun 02, 2008 by a Female patient taking Betapace (View Usage) (Dosage: Total Daily Dose: 160 Mg Unit Dose: 80 Mg) was diagnosed with atrial fibrillation (What is atrial fibrillation?), hypertension and. Location: UNITED STATES , 69 years of age, weighting 125.7 lb, Patient experienced the following unwanted or unexpected effects: heart rate irregular. During the same period patient was treated with TENORMIN (View Tenormin Review and Tenormin Label ), COUMADIN (View Coumadin Review and Coumadin Label ).

5950139-4 | No Adverse Event
on Oct 17, 2008 Male patient from UNITED STATES , 60 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Betapace (View Usage). Patient had the following side effects: no adverse event. Betapace dosage: Total Daily Dose: 240 Mg Unit Dose: 120 Mg.

5950128-X | Alopecia, Hearing Impaired, Hypersensitivity, Pruritus, Visual Impairment
on May 30, 2008 Female patient from UNITED STATES , 84 years of age, weighting 147.7 lb, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Betapace (View Usage). After Betapace was administered, patient had the following side effects: alopecia, hearing impaired, hypersensitivity, pruritus, visual impairment. Betapace dosage: Unit Dose: 40 Mg. During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ), PEPCID (View Pepcid Review and Pepcid Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), DIOVAN (View Diovan Review and Diovan Label ), GARAPENTINO (View Garapentino Review and Garapentino Label ).

5950124-2 | Epistaxis, Fatigue
Patient was taking Betapace (View Usage). Patient experienced the following unwanted or unexpected effects: epistaxis, fatigue on Nov 20, 2007 from UNITED STATES Additional patient health information: Male patient , 89 years of age, weighting 141.1 lb, was diagnosed with ventricular arrhythmia and. Betapace dosage: Total Daily Dose: 160 Mg. During the same period patient was treated with ACE (R) INHIBITOR (View Ace (r) Inhibitor Review and Ace (r) Inhibitor Label ), LIPITOR (View Lipitor Review and Lipitor Label ).

5944792-9 | Cardiac Arrest, Electrocardiogram Qt Prolonged, Torsade De Pointes, Ventricular Fibrillation, Ventricular Tachycardia
Adverse event was reported on Nov 06, 2008 by a Male patient taking Betapace (View Usage) (Dosage: 120 Mg Twice Daily Po) was diagnosed with arrhythmia (What is arrhythmia?) and. Location: UNITED STATES , 67 years of age, weighting 194.0 lb, Patient had the following side effects: cardiac arrest (What is cardiac arrest?), electrocardiogram qt prolonged, torsade de pointes, ventricular fibrillation, ventricular tachycardia.

5938793-4 | Arteriosclerosis Coronary Artery, Atrial Fibrillation, Myocardial Infarction
on Oct 21, 2008 Female patient from UNITED STATES , 62 years of age, was diagnosed with heart rate increased and was treated with Betapace (View Usage). After Betapace was administered, patient had the following side effects: arteriosclerosis coronary artery, atrial fibrillation (What is atrial fibrillation?), myocardial infarction. Betapace dosage: .

5905469-9 |
on Sep 16, 2008 Female patient from UNITED STATES , 62 years of age, was diagnosed with heart rate increased and was treated with Betapace (View Usage). . Betapace dosage: .

5901320-1 | Depressed Level Of Consciousness
Patient was taking Betapace (View Usage). Patient had the following side effects: depressed level of consciousness on Sep 16, 2008 from UNITED STATES Additional patient health information: Female patient , 62 years of age, was diagnosed with heart rate increased and. Betapace dosage: .